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Abstract. 
 
Cell adhesion to the extracellular matrix
(ECM) is a requirement for proliferation that is typi-
cally lost in malignant cells. In the absence of adhesion,
nontransformed cells arrest in G1 with increased levels
of the cyclin-dependent kinase inhibitor p27. We have
reported previously that the degradation of p27 re-
quires its phosphorylation on Thr-187 and is mediated
by Skp2, an F-box protein that associates with Skp1,
Cul1, and Roc1/Rbx1 to form the SCF
 
Skp2
 
 ubiquitin li-
gase complex. Here, we show that the accumulation of
Skp2 protein is dependent on both cell adhesion and
growth factors but that the induction of Skp2 mRNA is
exclusively dependent on cell adhesion to the ECM.
Conversely, the expression of the other three subunits of
the SCF
 
Skp2
 
 complex is independent of cell anchorage.
Phosphorylation of p27 on Thr-187 is also not affected
signiﬁcantly by the loss of cell adhesion, demonstrating
that increased p27 stability is not dependent on p27 de-
phosphorylation. Signiﬁcantly, ectopic expression of
Skp2 in nonadherent G1 cells resulted in p27 downreg-
ulation, entry into S phase, and cell division. The ability
to induce adhesion-independent cell cycle progression
was potentiated by coexpressing Skp2 with cyclin D1
but not with cyclin E, indicating that Skp2 and cyclin
D1 cooperate to rescue proliferation in suspension
cells. Our study shows that Skp2 is a key target of ECM
signaling that controls cell proliferation.
Key words: F-box protein • SCF • Skp2 • p27 • cell
adhesion control
 
Introduction
 
Protein degradation by the ubiquitin-proteasome pathway
plays a fundamental role in the regulation of the eukary-
otic cell cycle (for reviews see Deshaies, 1999; Koepp et
al., 1999). Proteolysis of many G1 regulatory proteins
 
 
 
is
mediated by SCF ubiquitin ligases, each composed of four
major subunits, Skp1, Cul1, Rbx1/Roc1, and one of many
F-box proteins (Fbps).
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 There are 11 Fbps in budding yeast,
22 in 
 
Drosophila
 
 (Rubin et al., 2000), and 
 
 
 
38 in humans
(Cenciarelli et al., 1999; Winston et al., 1999). Fbps contain
an F-box, an 
 
 
 
40–amino acid motif that is necessary for
the interaction of Fbps with Skp1 (for review see Kipreos
and Pagano, 2000). Fbps also contain additional protein–
protein interaction domains such as leucine-rich repeats
and WD-40 domains that are involved in the recognition of
phosphorylated substrates. Thus, the substrate specificity
of SCFs is dictated by distinct Fbps that target proteins for
ubiquitin-mediated degradation.
The cyclin-dependent kinase (Cdk) inhibitor p27 nega-
tively regulates cyclin E–Cdk2 and cyclin A–Cdk2 com-
plexes, two kinases necessary for DNA replication. We have
reported previously that upon mitogenic stimulation p27 is
degraded through the ubiquitin-proteasome pathway (Pa-
gano et al., 1995) and that the ubiquitinylation of p27 is de-
pendent on its Cdk2-mediated phosphorylation and is stim-
ulated by its association to cyclin E–Cdk2 or cyclin A–Cdk2
complexes (Montagnoli et al., 1999). Accordingly, in vivo
and in vitro degradation of p27 requires its phosphorylation
on Thr-187 by Cdk2 (Sheaff et al., 1997; Vlach et al., 1997;
Nguyen et al., 1999). Skp2 is an Fbp first identified together
with Skp1 as interactors of the cyclin A–Cdk2 complex,
hence the name S phase kinase-associated proteins (Skps).
Stimulation of quiescent cells with growth factors induces
the expression of Skp2 in late G1 (Carrano et al., 1999;
Marti et al., 1999). This induction occurs through a stabiliza-
tion of Skp2 protein but without activating 
 
SKP2
 
 gene tran-
scription (Wirbelauer et al., 2000). We and others have dem-
onstrated that Skp2 is necessary for the ubiquitinylation and
subsequent degradation of p27 both in vivo (Carrano et al.,
1999; Sutterluty et al., 1999) and in vitro (Carrano et al.,
1999; Tsvetkov et al., 1999). In agreement with these find-
ings, interference of Skp2 function by microinjection of an
anti-Skp2 antibody into living adherent cells resulted in an
inhibition of the entry into S phase (Zhang et al., 1995).
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Abbreviations used in this paper: 
 
Act D, actinomycin D; Adh, adher-
ent; Cdk, cyclin-dependent kinase; Chx, cycloheximide; ECM, extracellu-
lar matrix; Fbp, F-box protein; Mab, mouse monoclonal antibody; PDL,
population doubling; SCF, Skp1, Cul1, and Fbp complex; Skp, S phase ki-
nase-associated protein; Susp, suspension. 
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Skp2-deficient mice are smaller than littermate controls,
and Skp2
 
 
 
/
 
 
 
 cells exhibit high levels of p27 and free cyclin E
(not bound to Cdk2), polyploidy, and multiple centrosomes
(Nakayama et al., 2000). In addition to studies demonstrat-
ing that Skp2 is a major player in the degradation of p27
bound to Cdk complexes, there is also evidence of a p27
translational control (Hengst and Reed, 1996) and a regula-
tion of p27 subcellular localization (Tomoda et al., 1999).
Cell adhesion to the extracellular matrix (ECM) is re-
quired for cell cycle progression through the G1 phase.
The cooperative action of cell adhesion and growth factors
results in the upregulation of cyclins and the downregula-
tion of Cdk inhibitors, permitting cells to pass through the
G1 restriction point and complete the cell cycle (for re-
views see Assoian, 1997; Giancotti and Ruoslahti, 1999). It
has been reported that the loss of substratum attachment
in fibroblasts induces a stabilization of p27 and an in-
creased association of p27 to Cdk2 with a subsequent de-
crease in its kinase activity (Fang et al., 1996; Schulze et
al., 1996; Zhu et al., 1996; Kawada et al., 1997; Resnitzky,
1997). Ultimately, the inhibition of Cdk2 activity results in
a G1 arrest. Similar findings were reported for epithelial,
arterial smooth muscle, and endothelial cells that were
prevented to bind the ECM (Croix et al., 1996; Koyama et
al., 1996; Huang et al., 1998). Thus, p27 accumulation plays
an important role in inducing a G1 block in response to
loss of adhesion. Yet, the mechanism through which p27
accumulates in nonadherent cells is not understood.
The relationship between cell adhesion and cell cycle,
particularly the regulation of p27 abundance by ECM–
dependent signals, prompted us to test the hypothesis that
Skp2 plays a role in this process. The results of these stud-
ies are herein presented.
 
Materials and Methods
 
Cell Cultures, Cell Synchronization, 
and Cell Cycle Analysis
 
IMR-90 cells are nontransformed nonimmortalized human diploid lung fi-
broblasts. After culturing for 2–3 d in the presence of 0.2% serum, 95% of
the cells showed a 2n DNA content by flow cytometry, and 
 
 
 
3% of the
IMR-90 cell population incorporated BrdU during a 24-h incubation period.
IMR-90 cells were obtained from American Type Culture Collection at
PDL (population doubling) 20 and grown in DME plus 10% FBS for 
 
 
 
40
total PDLs. Cells were counted at each passage, and the increase in PDL
was calculated as the log
 
2
 
-fold increase in cell number. Rat-6 cells are a
clonal line of rat embryo fibroblasts (Krauss et al., 1992). These cells are ad-
hesion-dependent nontumorigenic in nude mice and compared with the
widely used Rat-1 cells produce fewer colonies in soft agar and when trans-
fected with activated Ras. Rat-6 cells were cultured in DME plus 5% calf se-
rum. After culturing for 2–3 d in the presence of 0.2% serum, 90% of the
cells showed a 2n DNA content by flow cytometry, and 
 
 
 
10% of the Rat-6
cell population incorporated BrdU during a 24-h incubation period. This
10% background was subtracted in all analyses of BrdU incorporation to
highlight the differences observed under different adhesion conditions (see
below). Umbilical vein endothelial cells were obtained from Clonetics Corp.
and cultured as described (Tam et al., 1994) for four passages or less (pas-
saged at a 1:4 ratio). Hs913T, 293T, HeLa, and U2-OS cells were obtained
from American Type Culture Collection. Rat-6, IMR-90, and endothelial
cells were synchronized in G0/G1 by serum starvation for 48 h. To test the
effects of lack of adhesion to the ECM, quiescent cells were trypsinized and
reseeded on tissue culture–coated Petri dishes (adherent) or Petri dishes
coated with 1% agarose (suspension) using 0.5–1 
 
 
 
 10
 
6
 
 cells per 10-cm dish.
To study the relative effects of fibronectin and growth factors, trypsinized
quiescent cells were replated in the presence of a cocktail of purified growth
factors (10 ng/ml EGF, 10 ng/ml PDGF, and 10 mg/
 
 
 
l insulin) on tissue cul-
ture–coated dishes coated with fibronectin or poly-
 
L
 
-lysine as described
(Zhu et al., 1999). Colony formation in soft agar was done as described
(Guadagno et al., 1993). For cell cycle analyses, adherent cells were grown
on glass coverslips, labeled for 3 h with 10 
 
 
 
m BrdU, rinsed with PBS, and
fixed for 10 min in 
 
 
 
20
 
 
 
C methanol–acetone (1:1). Fixed cells were rehy-
drated in PBS at room temperature and processed for cell staining. Sus-
pended cells were also labeled for 3 h with 10 
 
 
 
m BrdU, but during the last
30 min of incubation cells were collected and pulled through a syringe to
break up cell clumps. Cells were then plated on glass coverslips that had
been coated (4 h at room temperature) with poly-
 
L
 
-lysine (5 
 
 
 
g/ml in PBS;
Sigma-Aldrich) for the remaining 20 min and finally fixed as described
above. Cells were stained for BrdU as described previously (Ohtsubo et al.,
1995) and counterstained with Hoechst to identify all nuclei. The percentage
of BrdU-labeled cells (BrdU-positive cells/Hoechst-positive cells 
 
 
 
 100) was
quantified using a fluorescence microscope. At least 300 cells were counted
for each sample, and each experiment was performed at least four times.
 
Retroviral-mediated Gene Transfer
 
Packaging GP-293 cells (CLONTECH Laboratories, Inc.) were trans-
fected with retroviral plasmids according to the manufacturer’s instruc-
tions. 48 h after transfection, the virus-containing medium was collected
and supplemented with 8 
 
 
 
g/ml polybrene (Sigma-Aldrich). Then, the cul-
ture medium of the target cells was replaced with this viral supernatant for
24 h. This infection process was repeated a second time after a 12-h recov-
ery in normal medium. The percentage of infected cells was quantified by
flow cytometry or immunofluorescence. In all cases, 
 
 
 
85% of the cells
were infected. Multiple genes were introduced sequentially.
 
Cycloheximide Treatment and Pulse–Chase Analysis
 
To measure protein half-lives, cells were incubated in the presence of 100
 
 
 
g/ml cycloheximide (Chx) (Sigma-Aldrich) diluted in DME. Pulse–chase
analysis was performed as described (Pagano et al., 1995) with the only
difference being that after a 30-min starvation cells were labeled for 30
min with 200 
 
 
 
Ci/ml of [
 
35
 
S]methionine and [
 
35
 
S]cysteine (51006; ICN
Biomedicals) and chased with medium for the indicated times.
 
Immunoreagents, Extract Preparation, Immunoblot 
Analysis, and Kinase Assay
 
Mouse monoclonal antibodies (Mabs) to Skp2 were produced using bacte-
rial Skp2 produced and purified as described (Schulman et al., 2000).
Mabs to Skp2 (Latres et al., 2001), cyclin D1 (Lukas et al., 1994), Ubc3
(Latres et al., 1999), cyclin E (Faha et al., 1993), and rabbit polyclonal an-
tibodies to Skp2 (Carrano et al., 1999), Cul1 (Latres et al., 1999), cyclin A
(Pagano et al., 1992), cyclin B (Pagano et al., 1992), cyclin D1 (Lukas et
al., 1994), Roc1 (Ohta et al., 1999), and Thr-187 phospho-site p27-specific
antibody (Carrano et al., 1999; Montagnoli et al., 1999) were described
previously. Mabs to p21 (C24420), p27 (K25020), and Skp1 (P46020) were
from Transduction Labs. Mab to Rb (14001A) was from Pharmingen, and
Mab to E2F-1 was from Santa Cruz Biotechnology, Inc. (sc-251). Rabbit
antibody to cyclin E (sc-481) was from Santa Cruz Biotechnology, Inc.
Protein extraction and immunoblot analysis were performed as described
(Carrano et al., 1999). Histone H1 kinase reactions were performed as de-
scribed (Pagano et al., 1992).
 
Northern Blot Analysis
 
Total RNA was extracted using Trizol reagent (GIBCO BRL) according
to the manufacturer’s instructions. For Northern blots, 15 
 
 
 
g of total
RNA was loaded per lane and fractionated in a 1% agarose/formaldehyde
gel. After transfer onto Hybond N
 
 
 
 membrane (Amersham Pharmacia
Biotech), blots were fixed by UV cross-linking and hybridized with a 
 
32
 
P
probe specific for human Skp2. A probe specific for glyceraldehyde 3-phos-
phate dehydrogenase (GAPDH) was used to confirm equal loading. To
measure mRNA half-lives, cells were incubated in the presence of 1 
 
 
 
g/ml
actinomycin D (Act D) diluted in DME.
 
Results
 
Adhesion-dependent Expression of Skp2
 
We determined the requirement of cell adhesion for the 
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expression of SCF
 
Skp2
 
 subunits and Ubc3, the ubiquitin
conjugating enzyme working in concert with the SCF
 
Skp2
 
complex, in nontransformed nonimmortalized human dip-
loid IMR-90 fibroblasts and in immortalized Rat-6 fibro-
blasts (Fig. 1). Monolayer cultures of these adhesion-
dependent fibroblasts were arrested in G0/G1 by serum
deprivation, trypsinized, and replated in the presence of
serum either in suspension or in monolayer. Both in Rat-6
fibroblasts and human diploid IMR-90 fibroblasts, Skp2
but not Cul1, Skp1, Roc1, and Ubc3 failed to accumulate
in nonadherent conditions. As reported previously, non-
adherent cells failed to degrade p27 and to express cyclin
A, cyclin D1, and p21, whereas cyclin E expression was not
dependent on adhesion (Guadagno et al., 1993; Kang and
Krauss, 1996; Zhu et al., 1996; Bottazzi et al., 2000). Simi-
larly, quiescent IMR-90 fibroblasts and quiescent normal
human endothelial cells stimulated with a cocktail of puri-
fied growth factors expressed Skp2 when plated on fi-
bronectin-coated dishes but not on dishes coated with
poly-
 
L
 
-lysine, a substratum that does not allow cell adhe-
sion-dependent signaling (data not shown). These results
indicate that Skp2 is a general target of ECM signals that
control the G1–S transition in nontransformed cells.
 
Enforced Expression of Skp2 Allows Entry 
into S Phase, p27 Downregulation, and Cell 
Division in the Absence of Adhesion
 
To determine if the regulation of Skp2 expression was
causally linked to the block in G1 observed in nonadher-
ent cells, we studied the phenotype of fibroblasts constitu-
tively expressing Skp2 and/or G1 cyclins from exogenous
cDNAs. To express these proteins in Rat-6 fibroblasts, we
used retroviral expression vectors and found that Skp2, cy-
clin D1, and cyclin E were all expressed in an adhesion-
independent manner at levels two- to fourfold higher than
those of the respective endogenous proteins (data not
shown). Infected fibroblasts were synchronized in G0/G1
and then replated for 12 h in the presence of serum either
in suspension or in monolayer. The percentage of cells in S
phase was then analyzed by BrdU incorporation (Fig. 2 A).
Adherent cells infected with either Skp2 or G1 cyclins
were still dependent on serum growth factors for BrdU in-
corporation similarly to noninfected cells, indicating that
enforced expression of these proteins did not produce a
general alteration of cell cycle progression. In contrast, sig-
nificant differences were observed in nonadherent cul-
tures: compared with control cells, a significant increase in
BrdU incorporation was observed in Skp2-expressing cells.
Similar results were obtained with cyclin D1-expressing
cells, in agreement with previously published results (Zhu
et al., 1996; Resnitzky, 1997). Interestingly, coexpression of
Skp2 and cyclin D1 induced a further increase in cells en-
tering S phase to a percentage comparable to that of cells
plated in adhesion. In contrast, cyclin E expression was un-
able to increase the number of BrdU-positive cells or to
enhance the effect of Skp2 when the two proteins were co-
expressed. These results show that the enforced expression
of Skp2 allows growth in the absence of substratum adhe-
sion and that Skp2 and cyclin D1 cooperate to fully rescue
entry into S phase in nonadherent Rat-6 cells.
Infected nonadherent cells also differed from each other
at the level of p27 and cyclin A expression (Fig. 2 B, lanes
13–18). As expected based on cyclin A function, all of the
cells that were able to enter into S phase also expressed cy-
clin A. However, only those expressing Skp2 showed a de-
crease in p27 levels, whereas cyclin D1–expressing cells
showed no decrease (Fig. 2 B, lanes 15 and 17). The ability
of cyclin D1 to induce entry into S phase in the presence of
high p27 levels is likely due to cyclin D1 ability to sequester
p27 from Cdk2 complexes (for review see Sherr and Rob-
erts, 1999). In agreement with the effects on cyclin A and
p27, Skp2 expression induced Cdk2 kinase activity as as-
sayed using histone H1 as a substrate (Fig. 2 C). Finally,
Skp2 expression allowed Rat-6 cells to enter mitosis and
complete multiple rounds of cell cycle division as shown by
their ability to form colonies in soft agar (Fig. 3 and Table I).
Rat-6 cells coinfected with Skp2 and cyclin D1 formed con-
siderably larger colonies than in the presence of either one
of the two. In sum, these results show that ectopic expres-
sion of Skp2 can induce adhesion-independent cell prolifer-
ation and that Skp2 and cyclin D1 cooperate in this process.
 
p27 Stabilization Is Not Dependent on Its 
Dephosphorylation in Proliferating Cells 
Transferred to Suspension
 
In contrast to Rat-6 cells, p27 is phosphorylated on Thr-
187 only in adherent IMR-90 cells but not in suspension
cells restimulated with serum (data not shown). Therefore,
it is possible that p27 accumulates not only because of the
absence of Skp2 but also because of its unphosphorylated
state. To distinguish whether p27 stabilization correlates
to Skp2 downregulation, p27 dephosphorylation, or both,
we used IMR-90–proliferating cells in which p27 is phos-
phorylated on Thr-187 as detected with a well-established
p27 phospho-Thr-187–specific antibody (Carrano et al.,
1999; Montagnoli et al., 1999) (Fig. 4, lane 1, fourth panel
from the top).
 
 
 
When proliferating cells are transferred to
suspension, they accumulate p27 because of an increase in
its protein stability (p27 half-life; Fig. 5 D, bottom panel).
Fig. 4 shows that proliferating IMR-90 fibroblasts plated in
suspension exited the cell cycle as demonstrated by (a) the
disappearance of cyclin A, (b) the increase in p27, (c) the
decrease in the levels of cyclin D1 and E2F-1, (d) the de-
phosphorylation of Rb, and (e) a decrease in BrdU incor-
poration overtime (data not shown). Under these condi-
tions, the overall amount of Skp2 decreased dramatically
by 12 h as detected using two different antibodies against
Skp2. The levels of all other proteins analyzed (Cul1,
Skp1, Roc1, cyclin E, and cyclin B) remained unchanged
in nonadherent cultures. For reasons that are not currently
clear, p21 accumulated in proliferating cells transferred to
suspension (Fig. 4, lanes 12–22, third panel from the top)
but not in quiescent cells stimulated with serum in suspen-
sion (Fig. 1). Interestingly, p27 phosphorylation on Thr-
187 could still be detected in nonadherent cells using a p27
phospho-Thr-187–specific antibody (Fig. 4, lanes 7–11,
fourth panel from the top). Indistinguishable results were
obtained with proliferating Rat-6 fibroblasts transferred to
suspension (data not shown). Altogether, these results in-
dicate that p27 dephosphorylation does not contribute to
an increase in p27 stability in cells withdrawing the cell cy-
cle in response to loss of substratum adhesion. 
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Accumulation of Skp2 Is Due to an Adhesion-dependent 
Serum-independent Induction of Skp2 mRNA
 
Skp2 expression in late G1 is regulated by growth factors
that block its ubiquitin-proteasome–mediated degradation
(Wirbelauer et al., 2000). To determine the mechanism
regulating the loss of Skp2 in nonadherent cells, we first
analyzed the levels of Skp2 mRNA. Northern blot analysis
showed that over time loss of cell adhesion induces a sig-
nificant decrease in the amount of Skp2 message both in
quiescent IMR-90 cells restimulated with serum (Fig. 5 A)
and in proliferating IMR-90 cells (Fig. 5 B). To determine
whether this decrease in Skp2 mRNA was dependent on
an acceleration of Skp2 mRNA processing and/or degra-
dation, we inhibited transcription with Act D and col-
lected cells at different times after treatment. Northern
blot analysis from these cells revealed that the half-life of
Skp2 mRNA is similar in adherent and nonadherent cells
(Fig. 5 C), suggesting that 
 
SKP2
 
 gene transcription and
not mRNA stability is controlled by adhesion. Finally, to
test whether protein degradation contributes to control
Skp2 levels in response to loss of cell adhesion as it does in
response to serum (Wirbelauer et al., 2000) we compared
Skp2 half-life in adherent and suspended IMR-90 using
Chx, an inhibitor of protein synthesis. Skp2 stability did
not change, whereas p27 half-life was prolonged in nonad-
herent cells (Fig. 5 D). Similar results were obtained in
pulse–chase experiments (Fig. 5 E). Thus, although growth
factors control Skp2 expression by increasing its protein
stability without influencing the accumulation of its tran-
script, the ECM controls the induction of Skp2 mRNA
without influencing Skp2 protein degradation rate.
 
Discussion
 
Our results show that cell adhesion to the ECM is required
for the expression of the Fbp Skp2. In the absence of cell
adhesion, both the Skp2 message and protein disappear,
but the enforced expression of Skp2 in nonadherent im-
mortalized fibroblasts allows p27 degradation and cell cy-
cle progression. In agreement with previous reports (Zhu
et al., 1996; Resnitzky, 1997), cyclin D1 expression induced
similar cell cycle effects due to the ability of cyclin D1 to
sequester p27 and to be activated by its association with
p27 (for review see Sherr and Roberts, 1999). Significantly,
we observed a cooperative effect between Skp2 and cyclin
D1 that induced S phase entry and cell division in nonad-
herent cells comparable to that of adherent cells. Thus, the
cell adhesion-dependent entry into S phase is subject to
dual control by the accumulation of both Skp2 and cyclin
D1 (Fig. 6). Ultimately, this results in the inactivation of
p27 (through degradation and sequestration) and subse-
quent activation of Cdk2. The elimination and/or inactiva-
tion of p27 appears to be a necessary step in allowing adhe-
sion-independent cell growth, yet it is not sufficient. In fact,
p27-deficient mouse embryonic fibroblasts do not enter S
phase if transferred to suspension and do not form colonies
in soft agar (our unpublished results). This is in agreement
Figure 1. Skp2 expression is cell adhesion dependent.
Rat-6 fibroblasts (lanes 1–9) and IMR-90 (lanes 10–18)
fibroblasts were synchronized in G0/G1 by serum de-
privation (lanes 1 and 10; indicated as 0 hours),
trypsinized, and then replated in the presence of serum
either in monolayer (adherent [Adh]; lanes 2–5 and 11–
14) or in suspension (Susp; lanes 6–9 and 15–18). Cells
were collected at the indicated times. Protein extracts
were analyzed by immunoblot with antibodies to the
indicated proteins. Rat-6 and IMR-90 showed similar
profiles of protein expression under both adhesion and
suspension conditions with the exception that p21 was
not expressed in Rat-6 (bottom). 
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with the notion that several pathways must be disrupted
for adhesion-independent growth to occur. Accordingly,
although Skp2 expression induces strong effects on the
proliferation of immortalized fibroblasts (Rat-6 and NIH
3T3), very modest effects are observed in nonimmortalized
diploid fibroblasts such as IMR-90 and mouse embryonic
fibroblasts (data not shown). This difference may reflect
the fact that immortalized cells have lost some adhesion-
dependent control that is still present in normal cells.
Interestingly, the ECM and growth factors increase the
levels of Skp2 and cyclin D1 by different mechanisms (Fig.
6). Adhesion-dependent signals induce the expression of
Skp2 mRNA, whereas growth factors increase Skp2 pro-
tein stability (Wirbelauer et al., 2000). The ECM induces
the expression of cyclin D1 mRNA and its translation,
whereas growth factors activate the transcription of the
 
CCND1
 
 gene and increase the stability of its product, cy-
clin D1 (for reviews see Assoian, 1997; Assoian and
Schwartz, 2001). These different mechanisms are comple-
mentary and underlie the cooperativity between cell adhe-
sion and growth factors in controlling cell proliferation.
Although Skp2 is the only subunit of the SCF
 
Skp2
 
 complex
to be regulated by the ECM and by growth factors, some
mitogenic and antimitogenic stimuli may control the ex-
pression of other subunits. For example, in response to
Figure 2. Ectopic expression of Skp2 in non-
adherent fibroblasts allows DNA replication,
p27 degradation, and Cdk2 activation. (A–C)
Rat-6 cells infected with retroviruses express-
ing the indicated proteins were synchronized
in G0/G1 by serum deprivation,
trypsinized, and then replated in
the presence of serum either in
monolayer (Adh) or in Susp.
Cells were collected 12 h later.
(A) The percentage of Rat-6
cells in S phase analyzed by
BrdU incorporation. The results
shown are the mean percentage
obtained from three representa-
tive experiments. (B) Immuno-
blotting of Rat-6 cell extracts
with antibodies to the indicated
proteins. (C) Cdk2 kinase activ-
ity assayed using histone H1
(HH1) as a substrate after im-
munoprecipitation of Cdk2 from
Rat-6 cellular extracts.
Figure 3. Expression of Skp2 allows cell division in nonadher-
ent fibroblasts. Rat-6 cells were infected with retroviruses ex-
pressing the indicated proteins and grown in semisolid agarose
for 3–4 wk. See Table I for details and quantification of results.
 
Table I. Soft Agar Colony Formation in Rat-6 Fibroblasts 
Infected with Various Retroviruses
 
Vector(s) Growth in soft agar (number of colonies) Size of colonies
 
Exp 1
 
*
 
Exp 2
 
‡
 
Exp 3
 
§
 
Exp 4
 
 
 
mm
 
Empty 1053
Skp2 304 180 265 107 0.06–0.12
Cyclin D1 398 357 526 162 0.09–0.26
Skp2 
 
  
 
cyclin D1 228 388 114 0.09–0.44
 
*A total of 2 
 
 
 
 10
 
3
 
 cells were seeded in 0.3% agar supplemented in 5% calf serum.
Colonies were scored after 4 wk of growth. Exp, experiment.
 
‡
 
A total of 10
 
4
 
 cells were seeded as in the legend to Exp 1.
 
§
 
A total of 10
 
4
 
 cells were seeded in 0.3% agar supplemented with 10% calf serum.
Colonies were scored after 3 wk of growth.
 
 
 
A total of 10
 
4
 
 cells were seeded as in the legend to Exp 3. The number of colonies
shown is the average of an experiment done in triplicate. 
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Figure 4. p27 stabilization is not dependent on its dephosphorylation in proliferating fibroblasts transferred to suspension. Proliferat-
ing IMR-90 fibroblasts (lanes 1, 12, and 23; indicated as 0 hours) were trypsinized and then either reseeded in monolayer (Adh; lanes
2–6, 13–17, and 24–28) or transferred to Susp (lanes 7–11, 18–22, and 29–33) for the indicated intervals. Cells were collected and protein
extracts were analyzed by immunoblot with antibodies to the indicated proteins. Lanes 1–11 were immunoblotted with a monoclonal
antibody to Skp2 (top) or a polyclonal antibody to Skp2 (second panel from the top). Lanes 1–11 in the fourth panel from the top were
immunoblotted with a phospho-site p27-specific antibody (Carrano et al., 1999; Montagnoli et al., 1999) to detect p27 phosphorylated
on Thr-187 (indicated as P-p27).
Figure 5. Cell adhesion-depen-
dent serum-independent accu-
mulation of Skp2 transcripts is
responsible for Skp2 accumula-
tion. (A) IMR-90 cells were syn-
chronized (Synchr cells) by serum
deprivation for 72 h (lanes 1
and 4; indicated as 0 hours),
trypsinized, replated in the pres-
ence of serum either to Susp
(lanes 2, 5, and 6) or in mono-
layer (Adh; lanes 3, 7, and 8) for
the indicated hours. Total
RNAs were prepared and pro-
cessed for Northern blotting us-
ing  32P-labeled  SKP2 cDNA
(top) or GAPDH cDNA (bot-
tom). (B) Proliferating asynchro-
nous IMR-90 cells (Asynchr cells)
were trypsinized (lane 1; indi-
cated as 0 hours) and then either
reseeded in Susp (lanes 2 and 3)
or in monolayer (Adh; lanes 4
and 5) for the indicated hours.
Total RNAs were prepared and
processed for Northern blotting
as in A. (C) Proliferating IMR-90
cells (lane 1; indicated as 0
hours) were trypsinized and
then replated in the presence of
Act D in monolayer (Adh; lanes
2–6) or Susp (lanes 7–11). Decay
of Skp2 mRNA was determined
by Northern blotting. No differ-
ences were observed if Act D
was added 2 h after replating
rather than from the beginning
(not shown). (D) Proliferating
IMR-90 cells were trypsinized
and then replated in monolayer (Adh; lanes 1–5) or Susp (lanes 6–10). 8 h after replating, cells were treated with Chx for the indicated in-
tervals. Decay of Skp2 and p27 was determined by immunoblotting. (E) Proliferating IMR-90 cells engineered to express Skp2 by retrovi-
ral infection were replated in monolayer (Adh; lanes 1–4) or Susp (lanes 5–8). 8–9 h after replating, cells were labeled with [35S]methionine
for 30 min and chased with medium for the indicated times. Extracts were then subjected to immunoprecipitation with an anti-Skp2 mono-
clonal antibody. 
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cell–cell contact inhibition, fibroblasts downregulate Cul1
expression, which in turn results in the stabilization of p27
(O’Hagan et al., 2000). It will be interesting to investigate
if the cellular abundance of Cks1, a Skp2-interacting pro-
tein shown recently by us and others to be necessary for a
high affinity binding between phosphorylated p27 and
Skp2 (Ganoth et al., 2001; Spruck et al., 2001) is regulated
by growth factors, the ECM, and other stimuli.
The yeast phosphatase Cdc14 is able to dephosphorylate
the Cdk inhibitor Sic1 causing its accumulation because
dephosphorylated Sic1 cannot be recognized by the SCF
ubiquitin ligase (for review see Zachariae and Nasmyth,
1999). Although a human Cdc14 homologue exists (Li et
al., 1997), no phosphatase appears to play a role in the sta-
bilization of p27 observed in proliferating cells transferred
to suspension. In fact, phosphorylation of p27 on Thr-187
is still detectable in nonadherent cells (Fig. 4). Likely, p27
is still phosphorylated by Cdk2 during the first 4–8 h after
replating the cells in suspension, since Cdk2 activity was
totally inhibited only between 12 and 16 h as indicated by
the state of Rb phosphorylation (Fig. 4, lanes 18–22) and
by measuring Cdk2 activity in vitro (data not shown). De-
spite the fact that p27 is present in its phosphorylated
form, p27 accumulates, since it cannot be degraded due to
the absence of Skp2. Thus, during cell cycle withdrawal in
response to loss of cell adhesion p27 stabilization is not de-
pendent on its dephosphorylation. Interesting, a recent pa-
per shows that p27 accumulates in its phosphorylated form
in response to ectopic PTEN expression in PTEN-deficient
cells (Mamillapalli et al., 2001). In agreement with our
data, these results indicate that p27 accumulation can be
regulated by mechanisms other than dephosphorylation.
It has been shown that infecting cells with a recombi-
nant adenovirus expressing Skp2 in serum starved fibro-
blasts (Sutterluty et al., 1999) or arrested hepatocytes
(Nelsen et al., 2001) induces degradation of p27, Cdk acti-
vation, and S phase entry. This is in apparent contrast with
our results in both fibroblasts (Fig. 2) and thymocytes (La-
tres et al., 2001) where the presence of Skp2 alone is un-
able to produce such effects in resting cells. This discrep-
ancy is probably due to the difference in overexpression
levels obtained using different viral systems.
Adhesion independence, one of the fundamental prop-
erties of cancer cells, is associated with invasiveness and
metastasis (Folkman and Moscona, 1978). Changes in the
expression of cyclins and Cdk inhibitors have been impli-
cated in the adhesion-independent growth of tumor cells
(Fang et al., 1996; Orend et al., 1998). Destabilization of
p27 that we and others have documented in human epithe-
lial cancers and lymphomas correlates with tumor aggres-
siveness, poor prognosis (Esposito et al., 1997; Loda et al.,
1997; Steeg and Abrams, 1997; Piva et al., 1999; Chiarle et
al., 2000), and with the presence of metastases (Thomas et
al., 1998). We and others have shown recently that Skp2
levels inversely correlate with p27 expression in human
lymphomas (Latres et al., 2001), oral squamous cell carci-
nomas (Gstaiger et al., 2001), colorectal cancers (Hershko
et al., 2001), and prostate carcinomas (our unpublished re-
sults). Significantly, Skp2 cooperates with activated N-Ras
in an in vivo model of lymphomagenesis (Latres et al.,
2001). In contrast to all nontransformed cells tested (hu-
man, mouse, and rat fibroblasts and human endothelial
cells), transformed cells (such as HeLa, 293T, Hs913T, and
U2-OS cells) express the same levels of Skp2 regardless of
their adhesion conditions (our unpublished results). The
data presented herein support and extend previous studies
demonstrating that Skp2 is necessary for entering S phase
(Zhang et al., 1995; Sutterluty et al., 1999). Furthermore,
our findings show that Skp2 is a target of cell adhesion-
dependent signaling and together with the high Skp2 lev-
els observed in human cancers suggests a role for Skp2 in
the adhesion-independent ability of tumor cells to grow.
Figure 6. Model for the
function of Skp2 in adhe-
sion-dependent cell cycle
progression. The cooperation
between ECM–dependent sig-
nals and growth factor signal-
ing pathways (GFs) induces
by different mechanism the
expression of Skp2 and cyclin
D1, which in turn induce p27
degradation and p27 seques-
tration, respectively. The in-
hibition of p27 contributes
to the activation of cyclin
E–Cdk2 to promote entry
into the S phase of the cell
division cycle. See text for
details. 
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